All News
Psoriatic Pregnancies Pose Risks to the Mother, Not Child
A metanalysis of pregnancy outcomes in women with psoriasis and psoriatic arthritis finds an excess risk of adverse maternal events, but not adverse neonatal events.
This systematic review included 16 studies meeting inclusion criteria.
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast – Coconspirators: RA and Lung Disease
Dr. Jack Cush reviews and discusses more than a dozen news and journal articles from the past week on RheumNow.com.
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)
Autoimmune Risk of Death Up during COVID
A population-based study in the UK shows that patients with rare autoimmune rheumatic diseases (RAIRD) were 44% more likely to die during the 2020 COVID-19 pandemic (March - April) compared to either the general population or their pre-COVID risk.
Read ArticleRheumNow Podcast – Upadacitinib Wins in PsA (4.2.2021)
Dr Jack Cush reviews the news and Journal reports and takes "Back Talk" questions from viewers.
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)
Hypertension Unaffected by Urate Lowering Therapy
Does uric acid contribute to the risk of hypertension (HTN)? A recent cohort trial shows that allopurinol in young adults does not sufficiently lower blood pressure (BP).
Read ArticleRheumNow Podcast – Great Associations (3.19.2021)
Dr. Jack Cush rants on the journal reports, news and FDA actions featured this past week on RheumNow.com.
Read ArticleApremilast Equals MTX in Palmoplantar Psoriasis
Palmoplantar psoriasis (PPP) is a therapeutically challenging variant of psoriasis; nonetheless, a prospective, randomized, active-controlled trial from India suggests that apremilast is effective and safe in patients with PPP.
Read ArticleMDA-5 Antibodies and Juvenile Dermatomyositis
A multicentre, retrospective study examined MSA profiles (by immunoprecipitation) from 96 juvenile idiopathic inflammatory myopathies (JIIM) at nine pediatric rheumatology centres in Japan. MSA were found in 85 of 96 cases with over 90% of patients having one of the following three MSA
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)
Higher Lupus Mortality Among Minority Populations
The February 19th MMWR reports that higher mortality rates in certain patients with systemic lupus erythematosus (SLE); data based on recent San Francisco County statistics showing a four fold higher mortality among Asian and Hispanic/Latina females with SLE.
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)
Links:
Dr. John Cush RheumNow ( View Tweet)